These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29922908)

  • 1. Application of pharmacogenetics in clinical practice: problems and solutions.
    Baskys A
    J Neural Transm (Vienna); 2019 Jan; 126(1):109-113. PubMed ID: 29922908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.
    Theken KN; Lee CR; Gong L; Caudle KE; Formea CM; Gaedigk A; Klein TE; Agúndez JAG; Grosser T
    Clin Pharmacol Ther; 2020 Aug; 108(2):191-200. PubMed ID: 32189324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpreting and Implementing Clinical Pharmacogenetic Tests: Perspectives From Service Providers.
    Hachad H; Ramsey LB; Scott SA
    Clin Pharmacol Ther; 2019 Aug; 106(2):298-301. PubMed ID: 31162629
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacogenetics in daily practice].
    van Gelder T; van Schaik RHN
    Ned Tijdschr Geneeskd; 2020 Jun; 164():. PubMed ID: 32608920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
    Mostafa S; Kirkpatrick CMJ; Byron K; Sheffield L
    J Neural Transm (Vienna); 2019 Jan; 126(1):5-18. PubMed ID: 30191366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics: Chasing Perfection.
    Gaedigk A
    Clin Pharmacol Ther; 2019 Aug; 106(2):265-270. PubMed ID: 31355458
    [No Abstract]   [Full Text] [Related]  

  • 7. Health regulatory communications of well-established safety-related pharmacogenomics associations in six developed countries: an evaluation of alignment.
    Tan-Koi WC; Lim ES; Teo YY
    Pharmacogenomics J; 2017 Mar; 17(2):121-127. PubMed ID: 26902540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics: introduction and use in clinical practice.
    Saunders H; Harris D; Chirilă RM
    Rom J Intern Med; 2020 Jun; 58(2):69-74. PubMed ID: 32074077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Falls: the adverse drug reaction of the elderly and the impact of pharmacogenetics.
    Just KS; Schneider KL; Schurig M; Stingl JC; Brockmöller J
    Pharmacogenomics; 2017 Aug; 18(13):1281-1297. PubMed ID: 28776468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Utility and Economic Impact of CYP2D6 Genotyping.
    Reynolds KK; McNally BA; Linder MW
    Clin Lab Med; 2016 Sep; 36(3):525-42. PubMed ID: 27514466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics and tailored polypharmacy: an 80-year-old lady with rosuvastatin-associated rhabdomyolysis and maprotiline-related Ogilvie's syndrome
.
    Sreter KB; Barisic B; Popovic-Grle S
    Int J Clin Pharmacol Ther; 2017 May; 55(5):442-448. PubMed ID: 28257284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing: 2017 Update.
    Amstutz U; Henricks LM; Offer SM; Barbarino J; Schellens JHM; Swen JJ; Klein TE; McLeod HL; Caudle KE; Diasio RB; Schwab M
    Clin Pharmacol Ther; 2018 Feb; 103(2):210-216. PubMed ID: 29152729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogene Variation Consortium Gene Introduction: NUDT15.
    Yang JJ; Whirl-Carrillo M; Scott SA; Turner AJ; Schwab M; Tanaka Y; Suarez-Kurtz G; Schaeffeler E; Klein TE; Miller NA; Gaedigk A
    Clin Pharmacol Ther; 2019 May; 105(5):1091-1094. PubMed ID: 30515762
    [No Abstract]   [Full Text] [Related]  

  • 14. The challenges of implementing pharmacogenomic testing in the clinic.
    Moyer AM; Caraballo PJ
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation of pharmacogenomic drug labels into the clinic. Current problems.
    Ingelman-Sundberg M
    Pharmacol Res; 2020 Mar; 153():104620. PubMed ID: 31899313
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of comprehensive pharmacogenomic profiling to impact in-hospital prescribing.
    Lee YM; Danahey K; Knoebel RW; Ratain MJ; Meltzer DO; O'Donnell PH
    Pharmacogenet Genomics; 2019 Feb; 29(2):23-30. PubMed ID: 30531378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerations of pharmacogenetic testing in children.
    Haga SB; Solomon BD
    Pharmacogenomics; 2016 Jun; 17(9):975-7. PubMed ID: 27248426
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacogenetics-based personalized therapy: Levels of evidence and recommendations from the French Network of Pharmacogenetics (RNPGx).
    Picard N; Boyer JC; Etienne-Grimaldi MC; Barin-Le Guellec C; Thomas F; Loriot MA;
    Therapie; 2017 Apr; 72(2):185-192. PubMed ID: 28237406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomic considerations for medications in the perioperative setting.
    Jhun EH; Apfelbaum JL; Dickerson DM; Shahul S; Knoebel R; Danahey K; Ratain MJ; O'Donnell PH
    Pharmacogenomics; 2019 Jul; 20(11):813-827. PubMed ID: 31411557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Pharmacogenomics Within Precision Medicine: Challenges and Opportunities.
    Chenoweth MJ; Giacomini KM; Pirmohamed M; Hill SL; van Schaik RHN; Schwab M; Shuldiner AR; Relling MV; Tyndale RF
    Clin Pharmacol Ther; 2020 Jan; 107(1):57-61. PubMed ID: 31696505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.